D-Pharm Ltd.

Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses of Rifaximin.(Financial report)
Clinical Trials Week; 11/16/2009; 2146 words; Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced the successful outcome of two Phase...non-constipation irritable bowel syndrome," stated Bill Forbes, Pharm.D., Senior Vice President and Chief Development Officer, Salix Pharmaceuticals...

D-Pharm, Wanbang Pharma to co-develop stroke drug.
China Business News; 11/11/2009; 609 words; D-Pharm, Wanbang Pharma to co-develop...Aviv Stock Exchange-listed D-Pharm and Jiangsu Wanbang Biopharmaceuticals Co. Ltd. have entered an agreement...commercialization of DP-b99 in China, D-Pharm announced on Nov. 9. According...

D-Pharm Enters Into Collaboration With Wanbang Biopharmaceuticals to Increase the Potential Market for its Stroke Drug-Candidate DP-b99.
PR Newswire; 11/9/2009; 1240 words; ...REHOVOT, Israel, November 9 /PRNewswire-FirstCall/ -- D-Pharm Ltd. announced today that it has entered into a licensing...DP-b99 is a novel drug discovered and developed by D-Pharm for treatment of patients with acute ischemic stroke...

D-Pharm Enters Into Collaboration With Wanbang Biopharmaceuticals.(Clinical report)
Albawaba.com; 11/9/2009; 809 words; Summary: D-Pharm Ltd. (TASE: DPRM)announced today that it has entered D-Pharm Ltd. (TASE: DPRM)announced today that it has enteredinto a licensing...

Israel : D-Pharm in China stroke drug deal with Wanbang.
TendersInfo; 11/9/2009; 498 words; ...approval has been received. D-Pharm will also receive royalties...recovered from ischemic stroke, D-Phram said. DP-b99 may...form of sever disability. D-Pharm's Tel Aviv-listed shares...Copyright : Euclid Infotech Pvt. Ltd. Provided by Syndigate...